vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

DIVERSIFIED HEALTHCARE TRUST is the larger business by last-quarter revenue ($379.6M vs $197.9M, roughly 1.9× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -5.6%, a 12.3% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -0.0%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-166.4M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 1.2%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DHC vs RGEN — Head-to-Head

Bigger by revenue
DHC
DHC
1.9× larger
DHC
$379.6M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+13.7% gap
RGEN
13.6%
-0.0%
DHC
Higher net margin
RGEN
RGEN
12.3% more per $
RGEN
6.7%
-5.6%
DHC
More free cash flow
RGEN
RGEN
$184.0M more FCF
RGEN
$17.6M
$-166.4M
DHC
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
1.2%
DHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DHC
DHC
RGEN
RGEN
Revenue
$379.6M
$197.9M
Net Profit
$-21.2M
$13.3M
Gross Margin
52.5%
Operating Margin
-12.6%
9.0%
Net Margin
-5.6%
6.7%
Revenue YoY
-0.0%
13.6%
Net Profit YoY
75.7%
143.9%
EPS (diluted)
$-0.09
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
RGEN
RGEN
Q4 25
$379.6M
$197.9M
Q3 25
$388.7M
$188.8M
Q2 25
$382.7M
$182.4M
Q1 25
$386.9M
$169.2M
Q4 24
$379.6M
$174.1M
Q3 24
$373.6M
$154.9M
Q2 24
$371.4M
$154.1M
Q1 24
$370.8M
$151.3M
Net Profit
DHC
DHC
RGEN
RGEN
Q4 25
$-21.2M
$13.3M
Q3 25
$-164.0M
$14.9M
Q2 25
$-91.6M
$14.9M
Q1 25
$-9.0M
$5.8M
Q4 24
$-87.4M
$-30.3M
Q3 24
$-98.7M
$-654.0K
Q2 24
$-97.9M
$3.3M
Q1 24
$-86.3M
$2.1M
Gross Margin
DHC
DHC
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
DHC
DHC
RGEN
RGEN
Q4 25
-12.6%
9.0%
Q3 25
-43.4%
8.9%
Q2 25
-24.5%
7.6%
Q1 25
-2.7%
3.9%
Q4 24
-26.1%
-17.7%
Q3 24
-26.5%
-5.1%
Q2 24
-23.0%
1.0%
Q1 24
-23.7%
1.3%
Net Margin
DHC
DHC
RGEN
RGEN
Q4 25
-5.6%
6.7%
Q3 25
-42.2%
7.9%
Q2 25
-23.9%
8.2%
Q1 25
-2.3%
3.4%
Q4 24
-23.0%
-17.4%
Q3 24
-26.4%
-0.4%
Q2 24
-26.3%
2.2%
Q1 24
-23.3%
1.4%
EPS (diluted)
DHC
DHC
RGEN
RGEN
Q4 25
$-0.09
$0.24
Q3 25
$-0.68
$0.26
Q2 25
$-0.38
$0.26
Q1 25
$-0.04
$0.10
Q4 24
$-0.37
$-0.55
Q3 24
$-0.41
$-0.01
Q2 24
$-0.41
$0.06
Q1 24
$-0.36
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$105.4M
$767.6M
Total DebtLower is stronger
$2.4B
$542.2M
Stockholders' EquityBook value
$1.7B
$2.1B
Total Assets
$4.4B
$2.9B
Debt / EquityLower = less leverage
1.47×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
RGEN
RGEN
Q4 25
$105.4M
$767.6M
Q3 25
$201.4M
$748.7M
Q2 25
$141.8M
$708.9M
Q1 25
$302.6M
$697.2M
Q4 24
$144.6M
$757.4M
Q3 24
$256.5M
$784.0M
Q2 24
$265.6M
$809.1M
Q1 24
$207.1M
$780.6M
Total Debt
DHC
DHC
RGEN
RGEN
Q4 25
$2.4B
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$3.1B
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
RGEN
RGEN
Q4 25
$1.7B
$2.1B
Q3 25
$1.7B
$2.1B
Q2 25
$1.9B
$2.1B
Q1 25
$1.9B
$2.0B
Q4 24
$2.0B
$2.0B
Q3 24
$2.0B
$2.0B
Q2 24
$2.1B
$2.0B
Q1 24
$2.2B
$2.0B
Total Assets
DHC
DHC
RGEN
RGEN
Q4 25
$4.4B
$2.9B
Q3 25
$4.7B
$2.9B
Q2 25
$4.8B
$2.9B
Q1 25
$5.0B
$2.9B
Q4 24
$5.1B
$2.8B
Q3 24
$5.3B
$2.8B
Q2 24
$5.3B
$2.9B
Q1 24
$5.3B
$2.8B
Debt / Equity
DHC
DHC
RGEN
RGEN
Q4 25
1.47×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
1.56×
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
RGEN
RGEN
Operating Cash FlowLast quarter
$-19.6M
$25.7M
Free Cash FlowOCF − Capex
$-166.4M
$17.6M
FCF MarginFCF / Revenue
-43.8%
8.9%
Capex IntensityCapex / Revenue
38.7%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-280.3M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
RGEN
RGEN
Q4 25
$-19.6M
$25.7M
Q3 25
$-49.3M
$48.1M
Q2 25
$53.0M
$28.6M
Q1 25
$-3.2M
$15.0M
Q4 24
$112.2M
$39.2M
Q3 24
$21.1M
$49.3M
Q2 24
$44.3M
$42.2M
Q1 24
$28.6M
$44.7M
Free Cash Flow
DHC
DHC
RGEN
RGEN
Q4 25
$-166.4M
$17.6M
Q3 25
$-89.8M
$43.4M
Q2 25
$18.8M
$21.5M
Q1 25
$-42.9M
$11.4M
Q4 24
$-89.5M
$33.6M
Q3 24
$-26.1M
$42.3M
Q2 24
$3.3M
$37.4M
Q1 24
$-18.1M
$36.4M
FCF Margin
DHC
DHC
RGEN
RGEN
Q4 25
-43.8%
8.9%
Q3 25
-23.1%
23.0%
Q2 25
4.9%
11.8%
Q1 25
-11.1%
6.8%
Q4 24
-23.6%
19.3%
Q3 24
-7.0%
27.3%
Q2 24
0.9%
24.3%
Q1 24
-4.9%
24.0%
Capex Intensity
DHC
DHC
RGEN
RGEN
Q4 25
38.7%
4.1%
Q3 25
10.4%
2.5%
Q2 25
8.9%
3.9%
Q1 25
10.2%
2.1%
Q4 24
53.1%
3.2%
Q3 24
12.6%
4.5%
Q2 24
11.0%
3.1%
Q1 24
12.6%
5.5%
Cash Conversion
DHC
DHC
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons